Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins

被引:74
作者
Harmsen, MM [1 ]
Van Solt, CB [1 ]
Fijten, HPD [1 ]
Van Setten, MC [1 ]
机构
[1] Univ Wageningen & Res Ctr, Anim Sci Grp, ID Lelystad BV, NL-8219 PH Lelystad, Netherlands
关键词
single-domain antibody; vaccination; clearance;
D O I
10.1016/j.vaccine.2005.05.017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The therapeutic parenteral application of llama single-domain antibody fragments (VHHs) is hampered by their small size, resulting in a fast elimination from the body. Here we describe a method to increase the serum half-life of VHHs in pigs by fusion to another VHH binding to porcine immunoglobulin G (pIgG). We isolated 19 pIgG-binding VHHs from an immunized llama using phage display. Six VHHs were genetically fused to model VHH K609 that binds to Escherichia coli F4 fimbriae. All six yeast-produced genetic fusions of two VHH domains (VHH2s) were functional in ELISA and bound to pIgG with high affinity (1-33 nM). Four pIgG-binding VHH2s were administered to pigs and showed a 100-fold extended in vivo residence times as compared to a control VHH2 that does not bind to pIgG. This could provide the basis for therapeutic application of VHHs in pigs. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4926 / 4934
页数:9
相关论文
共 38 条
[1]   Pharmacokinetics and biodistribution of genetically engineered antibodies [J].
Batra, SK ;
Jain, M ;
Wittel, UA ;
Chauhan, SC ;
Colcher, D .
CURRENT OPINION IN BIOTECHNOLOGY, 2002, 13 (06) :603-608
[2]   History of the control of foot and mouth disease [J].
Blancou, J .
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2002, 25 (5-6) :283-296
[3]   THEORETICAL MODEL OF GAMMA-GLOBULIN CATABOLISM [J].
BRAMBELL, FW ;
HEMMINGS, WA ;
MORRIS, IG .
NATURE, 1964, 203 (495) :1352-&
[4]   Therapeutic antibody fragments with prolonged in vivo half-lives [J].
Chapman, AP ;
Antoniw, P ;
Spitali, M ;
West, S ;
Stephens, S ;
King, DJ .
NATURE BIOTECHNOLOGY, 1999, 17 (08) :780-783
[5]   Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs [J].
Conrath, KE ;
Lauwereys, M ;
Wyns, L ;
Muyldermans, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) :7346-7350
[6]  
CONVENTS D, 1999, Patent No. 9946300
[7]   Efficient tumor targeting by single-domain antibody fragments of camels [J].
Cortez-Retamozo, V ;
Lauwereys, M ;
Gh, GH ;
Gobert, M ;
Conrath, K ;
Muyldermans, S ;
De Baetselier, P ;
Revets, H .
INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (03) :456-462
[8]   The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease [J].
Dunn, CS ;
Samuel, AR ;
Pullen, LA ;
Anderson, J .
VIROLOGY, 1998, 247 (01) :51-61
[9]   Isolation of antigen specific Llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae [J].
Frenken, LGJ ;
van der Linden, RHJ ;
Hermans, PWJJ ;
Bos, JW ;
Ruuls, RC ;
de Geus, B ;
Verrips, CT .
JOURNAL OF BIOTECHNOLOGY, 2000, 78 (01) :11-21
[10]  
FRENYO VL, 1981, VET RES COMMUN, V4, P275